Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116187833 | 11618783 | 3 | F | 20160720 | 20151012 | 20160801 | PER | US-ASTRAZENECA-2015SE95085 | ASTRAZENECA | 0.00 | F | Y | 90.70000 | KG | 20160801 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116187833 | 11618783 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160 MCG/4.5 MCG, 2 PUFFS TWO TIMES A DAY | 3000995D00 | 21929 | BID | ||||||||
| 116187833 | 11618783 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | 22.3 | MG | CAPSULE | QD | |||||||
| 116187833 | 11618783 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | ||||||||||
| 116187833 | 11618783 | 4 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 116187833 | 11618783 | 5 | C | FIORICET | ACETAMINOPHENBUTALBITALCAFFEINE | 1 | Oral | AS REQUIRED | 0 | ||||||||||
| 116187833 | 11618783 | 6 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.25MG AS REQUIRED | 0 | .25 | MG | ||||||||
| 116187833 | 11618783 | 7 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | AS REQUIRED | 0 | ||||||||||
| 116187833 | 11618783 | 8 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | AS REQUIRED | 0 | ||||||||||
| 116187833 | 11618783 | 9 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 116187833 | 11618783 | 10 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Oral | 0 | 150 | MG | BID | ||||||||
| 116187833 | 11618783 | 11 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 0 | 1 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116187833 | 11618783 | 1 | Chronic obstructive pulmonary disease |
| 116187833 | 11618783 | 2 | Gastrooesophageal reflux disease |
| 116187833 | 11618783 | 5 | Migraine |
| 116187833 | 11618783 | 6 | Anxiety |
| 116187833 | 11618783 | 7 | Respiratory therapy |
| 116187833 | 11618783 | 8 | Chronic obstructive pulmonary disease |
| 116187833 | 11618783 | 9 | Lung disorder |
| 116187833 | 11618783 | 10 | Anxiety |
| 116187833 | 11618783 | 11 | Restless legs syndrome |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116187833 | 11618783 | Circumstance or information capable of leading to medication error | |
| 116187833 | 11618783 | Device malfunction | |
| 116187833 | 11618783 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116187833 | 11618783 | 1 | 201503 | 0 | ||
| 116187833 | 11618783 | 4 | 201502 | 0 | ||
| 116187833 | 11618783 | 7 | 201503 | 0 | ||
| 116187833 | 11618783 | 8 | 2000 | 0 | ||
| 116187833 | 11618783 | 9 | 2000 | 0 | ||
| 116187833 | 11618783 | 10 | 2005 | 0 | ||
| 116187833 | 11618783 | 11 | 2009 | 0 |